International Journal of Head and Neck Surgery

Register      Login

VOLUME 5 , ISSUE 2 ( May-August, 2014 ) > List of Articles

REVIEW ARTICLE

Targeting Angiogenesis

Mandeep Kaur

Citation Information : Kaur M. Targeting Angiogenesis. Int J Head Neck Surg 2014; 5 (2):78-86.

DOI: 10.5005/jp-journals-10001-1186

Published Online: 00-08-2014

Copyright Statement:  Copyright © 2014; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

How to cite this article

Kaur M. Targeting Angiogenesis. Int J Head Neck Surg 2014;5(2):78-86.


PDF Share
  1. Angiogenesis and apoptosis. Semin Cancer Biol 2003;13:159-167.
  2. Blood vessel maturation: vascular development comes of age. J Clin Invest 1999;103:157-158.
  3. Origin of endothelial progenitors in human post natal bone marrow. J Clin Invest 2002;109:337-346.
  4. VEGF regulates haematopoietic stem cell survival by an internal autocrine loop mechanism. Nature 2002;9:954-958.
  5. Anti-angiogenic cues from vascular basement membrane collagen. Cancer Res 2000;60:2520-2526.
  6. Angiogenesis promoted by vascular endothelial growth factor: regulation through α1β1 and α2β1 integrins. Proc Natl Acad Sci USA 1997;94:13612-13617.
  7. The C-terminus of type I collagen is a major binding site for heparin. Biochim Biophys Acta 1986;882:1-5.
  8. Canstatin, a novel matrix-derived inhibitor of angiogenesis and tumor growth. J Biol Chem 2000;275:1209-1215.
  9. Canstatin inhibits Akt activation and induces fas-dependent apoptosis in endothelial cells. J Biol Chem 2003; 278:37632-37636.
  10. New functions for non-collagenous domains of human collagen type IV. Novel integrin ligands inhibiting angiogenesis and tumor growth in vivo. J Biol Chem 2000;275:8051-8061.
  11. Endorepellin, a novel inhibitor of angiogenesis derived from the C terminus of perlecan. J Biol Chem 2003;278:4238-4249.
  12. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 1997;88:277-285.
  13. Endostatin causes G1 arrest of endothelial cells through inhibition of cyclin D1. J Biol Chem 2002;277:16464-16469.
  14. Interaction of endostatin with integrins implicated in angiogenesis. Proc Natl Acad Sci USA 2001;98:1024-1029.
  15. E-selectin is required for the antiangiogenic activity of endostatin. Proc Natl Acad Sci USA 2004;101:8005-8010.
  16. Endostatin inhibits endothelial and tumor cellular invasion by blocking the activation and catalytic activity of matrix metalloproteinase. Cancer Res 2000; 60:5410-5413.
  17. Antiangiogenic activity of restin, NC10 domain of human collagen XV: comparison to endostatin. Biochem Biophys Res Commun 1999;255:735-739.
  18. A fibronectin fragment inhibits tumor growth, angiogenesis, and metastasis. Proc Natl Acad Sci USA 2001;98: 620-624.
  19. Fibulin-5 antagonizes vascular endothelial growth factor (VEGF) signaling and angiogenic sprouting by endothelial cells. DNA Cell Biol 2004;23:367-379.
  20. The cell biology of thrombospondin-1. Matrix Biol 2000;19:597-614.
  21. Expression of the extracellular matrix molecule thrombospondin inversely correlates with malignant progression in melanoma, lung and breast carcinoma cell lines. Int J Cancer 1994;59:191-195.
  22. Thrombospondin-2 plays a protective role in multistep carcinogenesis: a novel host anti-tumor defense mechanism. EMBO J 2001;20:631-640.
  23. Identification of the anti-angiogenic site within vascular basement membrane derived tumstatin. J Biol Chem 2001;276:15240-15248.
  24. Physiological levels of tumstatin, a fragment of collagen IV α3 chain, are generated by MMP-9 proteolysis and suppress angiogenesis via αVβ3 integrin. Cancer Cell 2003;3:589-601.
  25. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 1994;79:315-328.
  26. Angiomotin: an angiostatin binding protein that regulates endothelial cell migration and tube formation. J Cell Biol 2001;152:1247-1254.
  27. Prothrombin kringle-2 domain has a growth inhibitory activity against basic fibroblast growth factorstimulated capillary endothelial cells. J Biol Chem 1998;273: 28805-28812.
  28. Cartilage-specific matrix protein, chondromodulin-I (ChM-I), is a strong angio-inhibitor in endochondral ossification of human neonatal vertebral tissues in vivo: relationship with angiogenic factors in the cartilage. Acta Histochem 2002;104:167-175.
  29. Flt-1 but not KDR/Flk-1 tyrosine kinase is a receptor for placenta growth factor, which is related to vascular endothelial growth factor. Cell Growth Differ 1996;7:213-221.
  30. Retinoic acid and interferon α act synergistically as antiangiogenic and antitumor agents against human head and neck squamous cell carcinoma. Cancer Res 1998;58:5551-5558.
  31. Inhibition of basic fibroblast growth factor expression, angiogenesis, and growth of human bladder carcinoma in mice by systemic interferon-α administration. Cancer Res 1998;58:808-814.
  32. Interleukin 1 is an autocrine regulator of human endothelial cell growth. Proc Natl Acad Sci USA 1990;87:6487-6491.
  33. Inhibition of angiogenesis in vivo by interleukin 12. J Natl Cancer Inst 1995;87:581-586.
  34. 2-Methoxyestradiol, an endogenous mammalian metabolite, inhibits tubulin polymerization by interacting at the colchicine site. Proc Natl Acad Sci USA 1994;91:3964-3968.
  35. Vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor: implications for ocular angiogenesis. Am J Ophthalmol 2004; 137:668-674.
  36. Pigment epithelium-derived factor (PEDF), a serpin with potent anti-angiogenic and neurite outgrowth-promoting properties. Biol Chem 2002;383:1677-1682.
  37. Overexpression of pigment epithelium-derived factor decreases angiogenesis and inhibits the growth of human malignant melanoma cells in vivo. Am J Pathol 2004;164:1225-1232.
  38. Roles of prolactin and related members of the prolactin/growth hormone/placental lactogen family in angiogenesis. J Endocrinol 2002; 173:219-238.
  39. Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides. Science 1990;247:77-79.
  40. Complex roles of tissue inhibitors of metalloproteinases in cancer. Oncogene 2002;21:2245-2252.
  41. Vasostatin, a calreticulin fragment, inhibits angiogenesis and suppresses tumor growth. J Exp Med 1998;188:2349-2356.
  42. Troponin I is present inhuman cartilage and inhibits angiogenesis. Proc Natl Acad Sci USA 1999;96:2645-2650.
  43. Role of angiopoietins and Tie receptor tyrosine kinases in angiogenesis and lymphangiogenesis. Cell and Tissue Research 2003;314(1):61-8.44.
  44. X-ray crystal structure of human acidic fibroblast growth factor. Biochemistry 35(7): 2086-2094.
  45. Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro. Biochem Biophys Res Commun 1992;189:824-831.
  46. VEGFs, receptors and angiogenesis. Semin Cancer Biol 1999;9:211.
  47. Circulating plasma VEGF response to exercise in sedentary and endurancetrained men. J Applied Physiology 2004;96(4):1445-1450.
  48. Matrix metalloproteinase activity is required for activity-induced angiogenesis in rat skeletal muscle. Am J Physiology. Heart and Circulatory Physiology 2000;279(4):540-547.
  49. Delta-like ligand 4 (Dll4) is induced by VEGF as a negative regulator of angiogenic sprouting. Proceedings of the National Academy of Sciences of the United States of America 2007;104(9):3219-3224.
  50. Robbins and cotran pathologic basis of disease. 7th ed. 47-118.
  51. Leukocytes, inflammation, and angiogenesis in cancer: fatal attractions. J Leukocyte Biology 2006;80:682-684.
  52. Angiogenesis in cancer and other diseases. Nature 2000;407:249-257.
  53. Hypoxic induction of human vascular endothelial growth factor expression through c-Src activation. Nature 1995;375:577-581.
  54. Establishing a link between oncogenes and tumor angiogenesis. Mol Med 1998;4:286-295.
  55. Regulation of angiogenic growth factors in the female reproductive tract by estrogens and progestins. Mol Endocrinol 1999;13:806-811.
  56. Revascularization of ischaemic tissue by PIGF treatment and inhibition of tumor angiogenesis, arthritis and artherosclerosis by anti Flt. Nat Med 2002;8:831-840.
  57. Identification for angiogenic mitogen selective for endocrine galand endothelium. Nature 2001;412:877-884.
  58. Angiogenic effect of extracellular HIV type I Tat 1 and its role in HIV associated kaposi sarcoma. Clin Microbiol Rev 2002;15:310-326.
  59. Adipose tissue mass can be regulated by vasculature. Proc Natl Acad USA 2002;99:10730-10735.
  60. Alzheimer disease. How does it start? J Alzheimes Dis 2002;10:497-512.
  61. Rescue of diabetes related impairment of angiogenesis by intramuscular gene therapy by adeno VEGF. Am J Pathol 1999;155:355-363.
  62. Ageing and survival of cutaneous microvasculature. J Invest Dermatol 2002;118:752-758.
  63. Impaired angiogenesis in ageing kidney: vascular endothelial growth factor and TSP 1 in renal disease. Am J Kidney Dis 2001;37:601-611.
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.